Procalcitonin kinetics within the first days of sepsis: Relationship with the appropriateness of antibiotic therapy and the outcome

Critical Care

Volumn 13, Issue 2, 2009, Pages

  Charles, Pierre Emmanuel ^a   Tinel, Claire ^a   Barbar, Saber ^a   Aho, Serge ^a   Prin, Sébastien ^a   Doise, Jean Marc ^a   Olsson, Nils Olivier ^a   Blettery, Bernard ^a   Quenot, Jean Pierre ^a  

^a HÔPITAL DU BOCAGE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN; PROCALCITONIN; ANTIINFECTIVE AGENT; BIOLOGICAL MARKER; CALCITONIN; PROTEIN PRECURSOR;

ADULT; ARTICLE; BACTEREMIA; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; EARLY INTERVENTION; ENTEROBACTERIACEAE; FEMALE; HUMAN; INTENSIVE CARE UNIT; LEGIONELLA PNEUMOPHILA; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OVERALL SURVIVAL; PATIENT MONITORING; PREDICTION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SEPSIS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS; STREPTOCOCCUS PNEUMONIAE; SURVIVAL RATE; TIME; TREATMENT OUTCOME; VENTILATOR ASSOCIATED PNEUMONIA; AGED; BLOOD; COHORT ANALYSIS; MIDDLE AGED; PATHOPHYSIOLOGY; SURVIVAL;

AGED; ANTI-BACTERIAL AGENTS; BIOLOGICAL MARKERS; CALCITONIN; COHORT STUDIES; FEMALE; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PROTEIN PRECURSORS; SEPSIS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 64049119735     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc7751     Document Type: Article

References (33)

1. Annane D Aegerter P Jars-Guincestre MC Guidet B Current epidemiology of septic shock: The cub-rea network Am J Respir Crit Care Med 2003, 168:165-172. 10.1164/rccm.2201087 12851245
2. Pittet D Tarara D Wenzel RP Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality JAMA 1994, 271:1598-1601. 10.1001/ jama.271.20.1598 8182812
3. Garrouste-Orgeas M Timsit JF Tafflet M Misset B Zahar JR Soufir L Lazard T Jamali S Mourvillier B Cohen Y De Lassence A Azoulay E Cheval C Descorps-Declere A Adrie C Costa de Beauregard MA Carlet J Excess risk of death from intensive care unit-acquired nosocomial bloodstream infections: A reappraisal Clin Infect Dis 2006, 42:1118-1126. 10.1086/ 500318 16575729
4. Munson EL Diekema DJ Beekmann SE Chapin KC Doern GV Detection and treatment of bloodstream infection: Laboratory reporting and antimicrobial management J Clin Microbiol 2003, 41:495-497. 149611 12517905 10.1128/JCM.41.1.495-497.2003
5. Rivers E Nguyen B Havstad S Ressler J Muzzin A Knoblich B Peterson E Tomlanovich M Early goal-directed therapy in the treatment of severe sepsis and septic shock N Engl J Med 2001, 345:1368-1377. 10.1056/ NEJMoa010307 11794169
6. Luna CM Aruj P Niederman MS Garzon J Violi D Prignoni A Rios F Baquero S Gando S Appropriateness and delay to initiate therapy in ventilator-associated pneumonia Eur Respir J 2006, 27:158-164. 10.1183/ 09031936.06.00049105 16387949
7. Munford RS Pugin J Normal responses to injury prevent systemic inflammation and can be immunosuppressive Am J Respir Crit Care Med 2001, 163:316-321. 11179099
8. Ibrahim EH Sherman G Ward S Fraser VJ Kollef MH The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting Chest 2000, 118:146-155. 10.1378/ chest.118.1.146 10893372
9. Harbarth S Garbino J Pugin J Romand JA Lew D Pitet D Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis Am J Med 2003, 115:529-535. 10.1016/j.amjmed.2003.07.005 14599631
10. Christ-Crain M Muller B Procalcitonin in bacterial infections - hype, hope, more or less? Swiss Med Wkly 2005, 135:451-460. 16208582
11. Riche FC Cholley BP Panis YH Laisne MJ Briard CG Graulet AM Gueris JL Valleur PD Inflammatory cytokine response in patients with septic shock secondary to generalized peritonitis Crit Care Med 2000, 28:433-437. 10.1097/00003246-200002000-00024 10708179
12. Bonten MJ Froon AH Gaillard CA Greve JW de Leeuw PW Drent M Stobberingh EE Buurman WA The systemic inflammatory response in the development of ventilator-associated pneumonia Am J Respir Crit Care Med 1997, 156:1105-1113. 9351609
13. Christ-Crain M Stolz D Bingisser R Muller C Miedinger D Huber PR Zimmerli W Harbarth S Tamm M Muller B Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: A randomized trial Am J Respir Crit Care Med 2006, 174:84-93. 10.1164/rccm.200512-1922OC 16603606
14. Nobre V Harbarth S Graf JD Rohner P Pugin J Use of procalcitonin to shorten antibiotic treatment duration in septic patients: A randomized trial Am J Respir Crit Care Med 2008, 177:498-505. 10.1164/ rccm.200708-1238OC 18096708
15. Harbarth S Holeckova K Froidevaux C Pittet D Ricou B Grau GE Vadas L Pugin J Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis Am J Respir Crit Care Med 2001, 164:396-402. 11500339
16. Schroder J Staubach KH Zabel P Stuber F Kremer B Procalcitonin as a marker of severity in septic shock Langenbecks Arch Surg 1999, 384:33-38. 10.1007/s004230050170 10367627
17. Gibot S Cravoisy A Kolopp-Sarda MN Bene MC Faure G Bollaert PE Levy B Time-course of sTREM (soluble triggering receptor expressed on myeloid cells)-1, procalcitonin, and C-reactive protein plasma concentrations during sepsis Crit Care Med 2005, 33:792-796. 10.1097/ 01.CCM.0000159089.16462.4A 15818107
18. Meisner M Tschaikowsky K Palmaers T Schmidt J Comparison of procalcitonin (pct) and c-reactive protein (crp) plasma concentrations at different sofa scores during the course of sepsis and mods Crit Care 1999, 3:45-50. 29013 11056723 10.1186/cc306
19. Luyt CE Guerin V Combes A Trouillet JL Ayed SB Bernard M Gibert C Chastre J Procalcitonin kinetics as a prognostic marker of ventilator-associated pneumonia Am J Respir Crit Care Med 2005, 171:48-53. 10.1164/rccm.200406-746OC 15447947
20. Claeys R Vinken S Spapen H ver Elst K Decochez K Huyghens L Gorus FK Plasma procalcitonin and C-reactive protein in acute septic shock: clinical and biological correlates Crit Care Med 2002, 30:757-762. 10.1097/00003246-200204000-00006 11940741
21. Clec'h C Ferriere F Karoubi P Fosse JP Cupa M Hoang P Cohen Y Diagnostic and prognostic value of procalcitonin in patients with septic shock Crit Care Med 2004, 32:1166-1169. 10.1097/01.CCM.0000126263.00551.06 15190968
22. Becker KL Snider R Nylen ES Procalcitonin assay in systemic inflammation, infection, and sepsis: Clinical utility and limitations Crit Care Med 2008, 36:941-952. 10.1097/CCM.0B013E318165BABB 18431284
23. Nylen ES Whang KT Snider RH Jr Steinwald PM White JC Becker KL Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis Crit Care Med 1998, 26:1001-1006. 10.1097/00003246-199806000-00015 9635646
24. Seligman R Meisner M Lisboa TC Hertz FT Filippin TB Fachel JM Teixeira PJ Decreases in procalcitonin and C-reactive protein are strong predictors of survival in ventilator-associated pneumonia Crit Care 2006, 10:R125. 1751074 16956405 10.1186/cc5036
25. Lisboa T Seligman R Diaz E Rodriguez A Teixeira PJ Rello J C-reactive protein correlates with bacterial load and appropriate antibiotic therapy in suspected ventilator-associated pneumonia Crit Care Med 2008, 36:166-171. 10.1097/01.CCM.0000297886.32564.CF 18007271
26. Charles PE Dalle F Aho S Quenot JP Doise JM Aube H Olsson NO Blettery B Serum procalcitonin measurement contribution to the early diagnosis of candidemia in critically ill patients Intensive Care Med 2006, 32:1577-1583. 10.1007/s00134-006-0306-3 16896850
27. Charles PE Ladoire S Aho S Quenot JP Doise JM Prin S Olsson NO Blettery B Serum procalcitonin elevation in critically ill patients at the onset of bacteremia caused by either gram negative or gram positive bacteria BMC Infect Dis 2008, 8:38. 2289831 18366777 10.1186/1471-2334-8-38
28. Jensen JU Heslet L Jensen TH Espersen K Steffensen P Tvede M Procalcitonin increase in early identification of critically ill patients at high risk of mortality Crit Care Med 2006, 34:2596-2602. 10.1097/01.CCM.0000239116.01855.61 16915118
29. Bossink AW Groeneveld AB Thijs LG Prediction of microbial infection and mortality in medical patients with fever: Plasma procalcitonin, neutrophilic elastase-alpha1-antitrypsin, and lactoferrin compared with clinical variables Clin Infect Dis 1999, 29:398-407. 10.1086/520222 10476749
30. Phua J Koay ES Lee KH Lactate, procalcitonin, and amino-terminal pro-B-type natriuretic peptide versus cytokine measurements and clinical severity scores for prognostication in septic shock Shock 2008, 29:328-333. 10.1097/SHK.0b013e318150716b 18277855
31. Boussekey N Leroy O Alfandari S Devos P Georges H Guery B Procalcitonin kinetics in the prognosis of severe community-acquired pneumonia Intensive Care Med 2006, 32:469-472. 10.1007/s00134-005-0047-8 16477418
32. Amour J Birenbaum A Langeron O Le Manach Y Bertrand M Coriat P Riou B Bernard M Hausfater P Influence of renal dysfunction on the accuracy of procalcitonin for the diagnosis of postoperative infection after vascular surgery Crit Care Med 2008, 36:1147-1154. 10.1097/ CCM.0b013e3181692966 18379240
33. Jensen JU Lundgren B Hein L Mohr T Petersen PL Andersen LH Lauritsen AO Hougaard S Mantoni T Bømler B Thornberg KJ Thormar K Løken J Steensen M Carl P Petersen JA Tousi H Søe-Jensen P Bestle M Hestad S Andersen MH Fjeldborg P Larsen KM Rossau C Thomsen CB Ostergaard C Kjaer J Grarup J Lundgren JD The Procalcitonin And Survival Study (PASS) - a randomised multi-center investigator-initiated trial to investigate whether daily measurements biomarker Procalcitonin and pro-active diagnostic and therapeutic responses to abnormal Procalcitonin levels, can improve survival in intensive care unit patients. Calculated sample size (target population): 1000 patients BMC Infect Dis 2008, 8:91. 2491622 18620598 10.1186/1471-2334-8-91